PMV Pharmaceuticals, Inc.
NASDAQ:PMVP
1.51 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 1.257 | 0.65 | 1.281 | 0.318 | 0.388 | 0.338 |
| Gross Profit
| -1.257 | -0.65 | -1.281 | -0.318 | -0.388 | -0.338 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 54.628 | 51.988 | 36.493 | 23.933 | 20.759 | 13.853 |
| General & Administrative Expenses
| 24.247 | 25.052 | 21.8 | 11.009 | 5.878 | 5.039 |
| Selling & Marketing Expenses
| 24.223 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 24.247 | 25.052 | 21.8 | 11.009 | 5.878 | 5.039 |
| Other Expenses
| 0 | 0.087 | 0.021 | -0.143 | -0.008 | 0.016 |
| Operating Expenses
| 78.875 | 77.04 | 58.293 | 34.942 | 26.637 | 18.892 |
| Operating Income
| -80.132 | -77.04 | -58.293 | -34.942 | -26.637 | -18.892 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 11.174 | 3.714 | 0.47 | 0.508 | 1.293 | 0.016 |
| Income Before Tax
| -68.958 | -73.326 | -57.823 | -34.434 | -25.344 | -17.535 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0.002 | -0.009 | 0.023 | 0.006 | 0.008 | 0.003 |
| Net Income
| -68.96 | -73.317 | -57.846 | -34.44 | -25.352 | -17.538 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -1.44 | -1.61 | -1.28 | -0.77 | -0.59 | -0.56 |
| EPS Diluted
| -1.44 | -1.61 | -1.28 | -0.77 | -0.59 | -0.56 |
| EBITDA
| -78.875 | -77.04 | -58.293 | -34.942 | -26.249 | -18.554 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 |